EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas
Clinical trial NCT01257594 · COMPLETED
Trial details
- NCT number
- NCT01257594
- Sponsor
- Andrew B Lassman, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-07
- Primary completion
- 2016-11-22
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.